Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

4.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
4.1K
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

895
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
895
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

8.7K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.7K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

5.4K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GenOT: generative optimal transport enables spatiotemporal interpolation and generation in cross-platform spatial transcriptomics.

Genome biology·2026
Same author

Large Language Models Enable Semantic Alignment for Cold-Start Compound-Protein Interaction Prediction.

IEEE journal of biomedical and health informatics·2026
Same author

Uncertainty-aware graph structure optimization with ensemble learning for enhanced cancer gene identification.

Cell reports methods·2026
Same author

MGAPep: LLM-Augmented Multimodal Graph Attention for Protein-Peptide Binding Site Prediction and Cross-Domain Transfer.

IEEE journal of biomedical and health informatics·2026
Same author

CryoSIP: unleashing protein high-resolution Cryo-EM via semantic-instance collaborative picking.

Briefings in bioinformatics·2026
Same author

A label masked autoencoder for image-guided segmentation label completion.

Patterns (New York, N.Y.)·2026

Related Experiment Video

Updated: Jul 24, 2025

mirMachine: A One-Stop Shop for Plant miRNA Annotation
06:16

mirMachine: A One-Stop Shop for Plant miRNA Annotation

Published on: May 1, 2021

2.6K

GCFMCL: predicting miRNA-drug sensitivity using graph collaborative filtering and multi-view contrastive learning.

Jinhang Wei1, Linlin Zhuo2, Zhecheng Zhou1

  • 1College of Data Science and Artificial Intelligence, Wenzhou University of Technology, 325027 Wenzhou, China.

Briefings in Bioinformatics
|July 10, 2023
PubMed
Summary
This summary is machine-generated.

This study introduces GCFMCL, a novel deep learning model for predicting miRNA-drug sensitivity. GCFMCL enhances accuracy by using multi-view contrastive learning on graph data, outperforming existing methods.

Keywords:
collaborative filteringdrugmiRNAmulti-view contrastive learningsensitivity

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

807
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

Related Experiment Videos

Last Updated: Jul 24, 2025

mirMachine: A One-Stop Shop for Plant miRNA Annotation
06:16

mirMachine: A One-Stop Shop for Plant miRNA Annotation

Published on: May 1, 2021

2.6K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

807
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.7K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • MicroRNA (miRNA) mechanisms are crucial for drug action, impacting drug discovery and biomarker research.
  • Traditional experimental methods for miRNA-drug susceptibility are costly and time-consuming.
  • Existing deep learning methods struggle with sparse data and complex feature information in miRNA-drug interactions.

Purpose of the Study:

  • To develop an efficient and accurate computational model for predicting miRNA-drug sensitivity.
  • To address limitations in current deep learning approaches for analyzing miRNA-drug relationships.
  • To leverage multi-view contrastive learning within a graph collaborative filtering framework.

Main Methods:

  • Proposed GCFMCL, a graph collaborative filtering model incorporating multi-view contrastive learning.
  • Developed topological contrastive learning using neighborhood information.
  • Implemented feature contrastive learning to mine high-order feature correlations and neighborhood relationships.

Main Results:

  • GCFMCL achieved high performance with AUC of 95.28%, AUPR of 95.66%, and F1-score of 89.77% on a dataset of 2049 miRNA-drug associations.
  • The model significantly outperformed state-of-the-art methods.
  • Multi-view contrastive learning effectively mitigated issues of sparse data and noise.

Conclusions:

  • GCFMCL offers a powerful new approach for predicting miRNA-drug sensitivity.
  • The model's performance demonstrates the effectiveness of multi-view contrastive learning in this domain.
  • This work provides a valuable tool for drug target discovery and related research.